Literature DB >> 24307816

Sequential Analysis of the Cox Model under Response Dependent Allocation.

Xiaolong Luo1, Gongjun Xu, Zhiliang Ying.   

Abstract

Sellke and Siegmund (1983) developed the Brownian approximation to the Cox partial likelihood score as a process of calendar time, laying the foundation for group sequential analysis of survival studies. We extend their results to cover situations in which treatment allocations may depend on observed outcomes. The new development makes use of the entry time and calendar time along with the corresponding σ-filtrations to handle the natural information accumulation. Large sample properties are established under suitable regularity conditions.

Entities:  

Keywords:  Brownian approximation; Survival analysis; clinical trials; group sequential methods; outcome dependent allocation; proportional hazards regression; staggered entry; weak convergence

Year:  2013        PMID: 24307816      PMCID: PMC3846285          DOI: 10.5705/ss.2012.147s

Source DB:  PubMed          Journal:  Stat Sin        ISSN: 1017-0405            Impact factor:   1.261


  4 in total

1.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

2.  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

Authors: 
Journal:  JAMA       Date:  1982-03-26       Impact factor: 56.272

3.  The BATTLE trial: personalizing therapy for lung cancer.

Authors:  Edward S Kim; Roy S Herbst; Ignacio I Wistuba; J Jack Lee; George R Blumenschein; Anne Tsao; David J Stewart; Marshall E Hicks; Jeremy Erasmus; Sanjay Gupta; Christine M Alden; Suyu Liu; Ximing Tang; Fadlo R Khuri; Hai T Tran; Bruce E Johnson; John V Heymach; Li Mao; Frank Fossella; Merrill S Kies; Vassiliki Papadimitrakopoulou; Suzanne E Davis; Scott M Lippman; Waun K Hong
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

4.  Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.

Authors:  Xian Zhou; Suyu Liu; Edward S Kim; Roy S Herbst; J Jack Lee
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

  4 in total
  1 in total

1.  Survival analysis following dynamic randomization.

Authors:  Xiaolong Luo; Mingyu Li; Gongjun Xu; Dongsheng Tu
Journal:  Contemp Clin Trials Commun       Date:  2016-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.